Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Operating Leases (2022 - 2025)

Praxis Precision Medicines has reported Operating Leases over the past 4 years, most recently at $110000.0 for Q4 2025.

  • Quarterly results put Operating Leases at $110000.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $110000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $110000.0, changed 0.0%.
  • Operating Leases for Q4 2025 was $110000.0 at Praxis Precision Medicines, roughly flat from $110000.0 in the prior quarter.
  • Over the last five years, Operating Leases for PRAX hit a ceiling of $3.5 million in Q4 2022 and a floor of $110000.0 in Q4 2024.
  • Median Operating Leases over the past 4 years was $1.7 million (2023), compared with a mean of $1.7 million.
  • Biggest five-year swings in Operating Leases: crashed 91.96% in 2024 and later changed 0.0% in 2025.
  • Praxis Precision Medicines' Operating Leases stood at $3.5 million in 2022, then plummeted by 60.89% to $1.4 million in 2023, then crashed by 91.96% to $110000.0 in 2024, then changed by 0.0% to $110000.0 in 2025.
  • The last three reported values for Operating Leases were $110000.0 (Q4 2025), $110000.0 (Q4 2024), and $436000.0 (Q3 2024) per Business Quant data.